The insulin dosage market size value per capita in Poland has seen significant fluctuations from 2012 to 2022. The value peaked in 2014 but experienced a steady decline from 2016 onwards, with a slight recovery in 2017 and 2021. The last two years before 2024 showed negative year-on-year variations, with 2022 closing lower than previous years.
Future trends to watch for include advancements in insulin delivery technologies, potential regulatory changes, and evolving market dynamics influenced by healthcare policies and demographic shifts. These factors could stabilize or potentially reverse the declining trend observed in recent years.
| # | 22 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 29.7 | 2023 | View data | ||
| 2 | 2 United Kingdom | 27.44 | 2023 | View data | ||
| 3 | 3 Greece | 26.06 | 2023 | View data | ||
| 4 | 4 Netherlands | 24.72 | 2023 | View data | ||
| 5 | 5 Belgium | 21.98 | 2023 | View data | ||
| 16 | 16 Ireland | 11.52 | 2023 | View data | ||
| 17 | 17 Austria | 10.77 | 2023 | View data | ||
| 18 | 18 Poland | 8.14 | 2023 | |||
| 19 | 19 Switzerland | 6.34 | 2023 | View data | ||
| 20 | 20 China | 3.49 | 2023 | View data | ||
